首页 | 本学科首页   官方微博 | 高级检索  
     

经皮冠状动脉介入联合替罗非班治疗急性心肌梗死
引用本文:孙薇,刘蕾,时伟彬,傅春江. 经皮冠状动脉介入联合替罗非班治疗急性心肌梗死[J]. 检验医学与临床, 2014, 0(22): 3121-3122
作者姓名:孙薇  刘蕾  时伟彬  傅春江
作者单位:1. 第三军医大学大坪医院 信息科
2. 第三军医大学大坪医院 野战外科研究所
3. 第三军医大学大坪医院心血管内科,重庆,400042
摘    要:目的:探讨替罗非班治疗心肌梗死患者经皮冠状动脉介入治疗(PCI)后血运重建不良方面的临床疗效,为该类疾病的临床治疗提供参考。方法以第三军医大学大坪医院2009年2月至2013年1月收治的200例PCI术中出现“无复流”或“慢血流”的心肌梗死患者为研究对象,将其随机分为对照组和治疗组。对照组PCI术中加用硝酸甘油,治疗组加用硝酸甘油和替罗非班。观察两组患者的临床治疗效果。结果治疗后,对照组与治疗组患者的TIMI血流分级和TMP心肌灌注分级均有明显改善,且差异有统计学意义(P<0.05)。治疗组TIMI血流分级与TMP心肌灌注分级明显高于对照组,差异有统计学意义(P<0.05)。治疗后,两组患者的校正TIMI帧数均优于治疗前,且治疗组优于对照组,差异有统计学意义(P<0.05)。1周后,治疗组患者的左心室舒张末期直径和左心室射血分数均优于对照组,且组间差异有统计学意义(P<0.05)。结论PCI术中加用替罗非班能够有效改善急性心肌梗死患者的血运重建不良症状,其临床疗效比单独使用硝酸甘油时更为理想。

关 键 词:急性心肌梗死  替罗非班  慢血流  无复流  经皮冠状动脉介入治疗

A study about the clinical efficacy of PCI joint with tirofiban in patients with AMI
SUN Wei,LIU Lei,SHI Wei-bin,FU Chun-jiang. A study about the clinical efficacy of PCI joint with tirofiban in patients with AMI[J]. Laboratory Medicine and Clinic, 2014, 0(22): 3121-3122
Authors:SUN Wei  LIU Lei  SHI Wei-bin  FU Chun-jiang
Affiliation:SUN Wei, LIU Lei, SHI Wei-bin, FU Chun-jiang (Daping Hospital Affiliated to the Third Military Medical University 1. The information section;2. The department of pediatrics;3. The department of cardiology ,Chongqing 400042,China)
Abstract:Objective To investigate the clinical effect of tirofiban for the treatment of acute myocardial infarc‐tion(AMI) patients with poor blood supply after percutanecus coronary intervention(PCI) .Methods A total of 200 AMI patients with blood flowing slowly and no‐reflow were selected as the objects in Daping Hospital Affiliated to the Third Military Medical University from February 2009 to January 2013 .All the patients were divided into treat‐ment group and control group randomly .The control group was treated with nitroglycerin after PIC ,the treatment group was treated with nitroglycerin and tirofiban after PIC .Compared the clinical effect of the two groups after re‐ceived treatment .Results After treatment ,the thrombolysis in myocardial infarction (TIMI) flow grade and the my‐ocardial perfusion ( TMP) grade of the two groups were all better than those pre-treatment ,and the differences be‐tween pre-treatment and post -treatment were statistically significant (P〈0 .05) .The TIMI flow grade and the TMP grade of treatment group were higher than those of the control group ,and the difference was statistically signif‐icant (P〈0 .05) .The post-treatment corrected TIMI frame count (CTFC) of the two groups was better than that pre-treatment (P〈 0 .05) ,and the treatment group was better than control group (P〈 0 .05) .After treating 1 week ,the left ventricular end-diastolic dimension ( LVEDD) and left ventricular ejection fraction (LVEF) of treat‐ment group was better than those of the control group ,and the differences were statistically significant (P〈0 .05) . Conclusion Using tirofiban during the operation of PCI could effectively improve the adverse revascularization ,the clinical effect was better than nitroglycerin using alone .
Keywords:acute myocardial infarction  tirofiban  blood flowing slowly  no reflow  percutanecus coro-nary intervention
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号